Home / Investors Information / EDAP Presents Positive Results from Non-Inferiority Study Comparing Outcomes of Focal One HIFU Versus Radical Prostatectomy at EAU23 Read more about EDAP Presents Positive Results from Non-Inferiority Study Comparing Outcomes of Focal One HIFU Versus Radical Prostatectomy at EAU23 EDAP to Announce Fourth Quarter and Full-Year 2022 Financial Results on Thursday, March 30th Read more about EDAP to Announce Fourth Quarter and Full-Year 2022 Financial Results on Thursday, March 30th EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2022 Revenue Read more about EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2022 Revenue EDAP Announces Positive Results from Phase 2 Study Evaluating Therapeutic High-Intensity Focused Ultrasound (HIFU) for the Treatment of Rectal Endometriosis Read more about EDAP Announces Positive Results from Phase 2 Study Evaluating Therapeutic High-Intensity Focused Ultrasound (HIFU) for the Treatment of Rectal Endometriosis EDAP Announces Record Q4 US Focal One Placements Read more about EDAP Announces Record Q4 US Focal One Placements EDAP Appoints Medical Capital Equipment Finance Veteran Ken Mobeck as Chief Financial Officer of Company’s U.S. Subsidiary Read more about EDAP Appoints Medical Capital Equipment Finance Veteran Ken Mobeck as Chief Financial Officer of Company’s U.S. Subsidiary EDAP Announces Approval to Initiate Randomized Clinical Trial Evaluating Focal One® as a Potential Treatment for Rectal Deep Infiltrating Endometriosis Read more about EDAP Announces Approval to Initiate Randomized Clinical Trial Evaluating Focal One® as a Potential Treatment for Rectal Deep Infiltrating Endometriosis EDAP to Present at the Piper Sandler 34th Annual Healthcare Conference Read more about EDAP to Present at the Piper Sandler 34th Annual Healthcare Conference EDAP Reports Third Quarter 2022 Results Read more about EDAP Reports Third Quarter 2022 Results Michael Sarcone Michael Sarcone Jefferies Pagination First page « First Previous page ‹ Previous … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page Next › Last page Last » Subscribe to
EDAP Presents Positive Results from Non-Inferiority Study Comparing Outcomes of Focal One HIFU Versus Radical Prostatectomy at EAU23 Read more about EDAP Presents Positive Results from Non-Inferiority Study Comparing Outcomes of Focal One HIFU Versus Radical Prostatectomy at EAU23
EDAP to Announce Fourth Quarter and Full-Year 2022 Financial Results on Thursday, March 30th Read more about EDAP to Announce Fourth Quarter and Full-Year 2022 Financial Results on Thursday, March 30th
EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2022 Revenue Read more about EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2022 Revenue
EDAP Announces Positive Results from Phase 2 Study Evaluating Therapeutic High-Intensity Focused Ultrasound (HIFU) for the Treatment of Rectal Endometriosis Read more about EDAP Announces Positive Results from Phase 2 Study Evaluating Therapeutic High-Intensity Focused Ultrasound (HIFU) for the Treatment of Rectal Endometriosis
EDAP Announces Record Q4 US Focal One Placements Read more about EDAP Announces Record Q4 US Focal One Placements
EDAP Appoints Medical Capital Equipment Finance Veteran Ken Mobeck as Chief Financial Officer of Company’s U.S. Subsidiary Read more about EDAP Appoints Medical Capital Equipment Finance Veteran Ken Mobeck as Chief Financial Officer of Company’s U.S. Subsidiary
EDAP Announces Approval to Initiate Randomized Clinical Trial Evaluating Focal One® as a Potential Treatment for Rectal Deep Infiltrating Endometriosis Read more about EDAP Announces Approval to Initiate Randomized Clinical Trial Evaluating Focal One® as a Potential Treatment for Rectal Deep Infiltrating Endometriosis
EDAP to Present at the Piper Sandler 34th Annual Healthcare Conference Read more about EDAP to Present at the Piper Sandler 34th Annual Healthcare Conference
